A DNA reading-frame detail decides Rett syndrome severity
Not every mutation in the same gene leads to the same disease. In Rett syndrome, a severe neurological disorder affecting almost exclusively girls, the severity of the condition turns out to depend on a detail in the genetic code that had previously been overlooked.
Rett syndrome is caused by mutations in the MECP2 gene. A specific group of mutations that truncate the end of the gene (C-terminal deletions) had been difficult to interpret. Some carriers become severely ill; others do not. The researchers found that the difference lies in a technical detail: which reading frame of the DNA is activated after the mutation.
DNA is read in blocks of three letters (codons). When a piece of DNA is deleted, the reading frame shifts and different codons are read. The study, published in eLife, shows that mutations shifting the reading frame to the so-called +2 frame introduce a stop codon in a specific context (the PPX motif). This causes a strongly reduced level of the MECP2 protein, and thus disease. Mutations shifting to the +1 frame avoid this motif and are benign.
From prognosis to potential repair
This insight has two implications. First, it provides a reliable prognostic distinction. Clinicians can now better predict which patients with a C-terminal deletion are at risk for Rett syndrome.
Second, it opens a path toward gene therapy. The researchers showed that replacing the harmful stop codon with a tryptophan codon restores MECP2 protein levels and reduces Rett-like symptoms in a mouse model. A so-called adenine base editor, a tool that modifies individual DNA letters without breaking the strand, performed this efficiently in cultured cells.
Still a long road ahead
The results are promising but preliminary. The mouse model showed improvement, but translation to humans requires further safety and efficacy studies. In the broader longevity context, this is a compelling example of precision medicine: the idea that genetic variants must be assessed not in isolation but in their exact molecular context to design effective treatments.
Want to research this yourself?
Search for example:
- frameshift pathogenicity
- MECP2 gene therapy
- adenine base editing neurology